Hospitalization for influenza among patients with chronic obstructive pulmonary disease Source: International Congress 2019 – Airway infection in COPD Year: 2019
Should chronic obstructive pulmonary disease patients must be vaccinated? Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005
Influenza A virus in exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006
The prevelance of respiratory infections in vaccined patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011
Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006
Analysis of mortality in Japanese patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005
Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006
Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Reasons for hospitalisation patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002